Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Is It PMS Or PMDD?

Executive Summary

Markedly depressed mood Feelings of hopelessness Marked anxiety Marked lability Persistant anger Decreased interest in usual activities Subjective sense of difficulty in concentrating Lethargy, easy fatigability, or lack of energy Hypersomnia or insomnia Subjective sense of being overwhelmed or out of control Other physical symptoms

You may also be interested in...



Lilly Fluoxetine For Premenstrual Dysphoria Merits Separate Indication

Labeling for Lilly's fluoxetine (Prozac) should include a separate indication for premenstrual dysphoric disorder, FDA's Psychopharmacologic Drugs Advisory Committee agreed Nov. 3.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035137

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel